Association of white matter hyperintensities with migraine phenotypes and response to treatment

Sherihan Rezk Ahmed1, Amr Abdel Monem Mohamed2, Haitham Hamdy Salem2

  • 1Department of Neurology, Faculty of Medicine, Kafr el-Sheikh University, 12 Elgeish street, Kafr el-sheikh, 33511, Egypt. sherihanrezk2016@gmail.com.

Abstract

Insights

White matter hyperintensities (WMHs) are common in migraine patients, especially with aura, vomiting, or dizziness. These brain lesions are linked to poorer treatment response and increased disease severity.

Area of Science:

  • Neurology
  • Neuroimaging
  • Migraine Research

Background:

  • White matter hyperintensities (WMHs) are prevalent in migraineurs but their clinical significance remains unclear.
  • The association of WMHs with specific migraine phenotypes and treatment outcomes requires further investigation.

Purpose of the Study:

  • To evaluate the association between WMHs and various migraine phenotypes.
  • To explore the relationship between WMHs and patient response to migraine treatments.

Main Methods:

  • A cross-sectional study involving 500 migraineurs who underwent 3T MRI to assess WMHs.
  • Comparison of migraine phenotypes between patients with and without WMHs.
  • Classification of patients into treatment responder and non-responder groups based on symptom reduction.

Main Results:

  • 29% of patients exhibited WMHs, correlating with older age, longer disease duration, and higher attack frequency.
  • WMHs and higher Scheltens scores were more frequent in non-responders to acute and maintenance medications.
  • Migraine with aura, vomiting, and dizziness were identified as predictors for WMH development.

Conclusions:

  • WMHs are more common in migraine with aura, and associated with vomiting and dizziness.
  • WMH prevalence increases with age and disease severity.
  • Patients with WMHs demonstrated a poorer response to both acute and prophylactic migraine medications.

Related Concept Videos